TORONTO, March 17, 2016 /CNW/ – Transition Therapeutics Inc. (“Transition” or the “Company”) (NASDAQ: TTHI, TSX: TTH) today announced that it received written notification from The NASDAQ Stock Market (“NASDAQ”) on March 15, 2016 advising the Company that because the bid price of the…